Showing results (51-60 of 123) with videos related to

Sort By:
Pageof 13
Therapeutic Drug Monitoring|February 9, 2018
Development and Validation of a Bioanalytical Method to Quantitate Enzalutamide and its Active Metabolite N-Desmethylenzalutamide in Human Plasma: Application to Clinical Management of Patients With Metastatic Castration-Resistant Prostate CancerGuillemette E Benoist, Eric van der Meulen, Inge M van Oort, et al.
The Lancet. Oncology|September 2, 2022
The QT interval prolongation potential of anticancer and supportive drugs: a comprehensive overviewEline L Giraud, Kaylee R M Ferrier, Nienke A G Lankheet, et al.
Cancer Chemotherapy and Pharmacology|October 24, 2013
Midazolam as a phenotyping probe to predict sunitinib exposure in patients with cancerD de Wit, H Gelderblom, A Sparreboom, et al.
Therapeutic Drug Monitoring|October 2, 2014
Therapeutic drug monitoring to individualize the dosing of pazopanib: a pharmacokinetic feasibility studyDjoeke de Wit, Nielka P van Erp, Jan den Hartigh, et al.
Journal of Pharmaceutical and Biomedical Analysis|November 8, 2017
Development and validation of an analytical method using UPLC-MS/MS to quantify everolimus in dried blood spots in the oncology settingLotte M Knapen, Yvo de Beer, Roger J M Brüggemann, et al.
The Journal of Clinical Endocrinology and Metabolism|July 28, 2012
Sunitinib in refractory adrenocortical carcinoma: a phase II, single-arm, open-label trialMatthias Kroiss, Marcus Quinkler, Sarah Johanssen, et al.
Cancer Chemotherapy and Pharmacology|December 17, 2023
Real-world data on the management of pazopanib-induced liver toxicity in routine care of renal cell cancer and soft tissue sarcoma patientsK Westerdijk, S D Krens, N Steeghs, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|July 10, 2025
Elacridar improves sunitinib efficacy in colorectal cancer modelsDennis Poel, Kirti K Iyer, Bob van Gasteren, et al.
European Journal of Clinical Pharmacology|December 10, 2017
Clinical validation study of dried blood spot for determining everolimus concentration in patients with cancerA E C A B Willemsen, L M Knapen, Y M de Beer, et al.
JCO Precision Oncology|January 20, 2022
A Systematic Review and Meta-Analysis on the Predictive Value of Cell-Free DNA-Based Androgen Receptor Copy Number Gain in Patients With Castration-Resistant Prostate CancerSofie H Tolmeijer, Emmy Boerrigter, Jack A Schalken, et al.
Pageof 13